| Net Cash Provided by (Used in) Operating Activities |
$676,508,000 |
USD |
-326% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$1,200,695,000 |
USD |
117% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$524,187,000 |
USD |
33% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,869,177,000 |
USD |
164% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$372,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0 |
pure |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$2,517,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$1,888,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,145,000 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$14,000 |
USD |
|
Q1 2024 |
Q1 2024 |